SCHEMBL6192045

SCHEMBL6192045

NC(=O)C(Cc1ccccc1)N1CCCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.62
ALDH1A1 P00352 2/20 0.55
LMNA P02545 1/20 0.55
POLB P06746 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
TSHR P16473 5/20 0.55
HPGD P15428 2/20 0.55
GAA P10253 2/20 0.55
CYP3A4 P08684 2/20 0.53
CYP2C19 P33261 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2D6 P10635 1/20 0.53
PLAU P00749 3/20 0.51
PLAUR Q03405 3/20 0.51
EPHX1 P07099 1/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
PKM P14618 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12487367 0.98 RAB9A (0.59) RAB9AALDH1A1LMNAPOLBL3MBTL1
SCHEMBL4143905 0.87 LMNA (0.71) RAB9AALDH1A1LMNAPOLBL3MBTL1
SCHEMBL27910314 0.87 RAB9A (0.69) RAB9AALDH1A1LMNAPOLBL3MBTL1
Hydrochloric Acid SCHEMBL9096753 0.85 LMNA (0.69) RAB9AALDH1A1LMNAPOLBL3MBTL1
SCHEMBL11251072 0.84 SLC6A4 (0.55) RAB9AALDH1A1LMNAPOLBL3MBTL1
SCHEMBL20791842 0.84 SLC6A2 (0.49) RAB9AALDH1A1LMNAPOLBL3MBTL1
SCHEMBL18375212 0.84 SLC6A2 (0.49) RAB9AALDH1A1LMNAPOLBL3MBTL1
SCHEMBL5321539 0.83 ALDH1A1 (0.58) ALDH1A1LMNAPOLBL3MBTL1TSHR
SCHEMBL5322283 0.81 MAOB (0.55) ALDH1A1LMNAPOLBL3MBTL1TSHR
SCHEMBL1683002 0.80 RAB9A (0.58) RAB9AALDH1A1LMNAPOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-A4 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2005-03-30 EP disclosed
EP-1411942-A4 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2005-01-26 EP disclosed
EP-1465631-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI Pharmaceuticals, Inc. (US) 2004-10-13 EP disclosed
EP-1411942-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS Synaptic Pharmaceutical Corporation (US) 2004-04-28 EP disclosed
WO-2003053366-A2 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARMACEUTICALS, INC. (US) 2003-07-03 WO disclosed
WO-2003004027-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-01-16 WO disclosed